About this document
2017 VHD Clinician Tool by mattouschn is a document available to read on EtoBox.
The document outlines updated recommendations for antithrombotic therapy in patients with valvular heart disease, based on the 2017 AHA/ACC guidelines. Key changes include the use of DOACs for certain patients with atrial fibrillation and a CHA2DS2-VASc score ≥2, and considerations for lower INR targets for specific mechanical valves. It emphasizes the importance of anticoagulation in various scenarios while maintaining existing recommendations for certain treatments.
- Author
- mattouschn
- Language
- EN